本页面由Tiger Trade Technology Pte. Ltd.提供服务

Protagonist Therapeutics Inc

144.88
+1.150.80%
盘前:137.50-7.3800-5.09%07:05 EDT
成交量:89.85万
成交额:1.31亿
市值:93.75亿
市盈率:140.66
高:152.19
开:145.83
低:143.69
收:143.73
52周最高:160.81
52周最低:73.08
股本:6,470.83万
流通股本:6,316.60万
量比:0.98
换手率:1.42%
股息:- -
股息率:- -
每股收益(TTM):1.03
每股收益(LYR):-2.0500
净资产收益率:10.98%
总资产收益率:4.55%
市净率:11.14
市盈率(LYR):-70.67

数据加载中...

2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/10/16

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/20

重要事件披露

Form 8-K - Current report
2024/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/07/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities